Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Muscle force displacement device in comfortable anesthesia for eye surgery
ChiCTR2200063061Phase 4Not yet recruiting
- Sponsor
- Hangzhou Plastic Surgery Hospital
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam, alfentanil and lidocaine (2 arms), sponsored by Hangzhou Plastic Surgery Hospital. Primary endpoint: fine muscle strength. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
remimazolamalfentanillidocaine
Beyond the preview
Go deeper on ChiCTR2200063061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063061.